Correlation Between Caribou Biosciences and Conduit Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and Conduit Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and Conduit Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Caribou Biosciences and Conduit Pharmaceuticals, you can compare the effects of market volatilities on Caribou Biosciences and Conduit Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of Conduit Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and Conduit Pharmaceuticals.

Diversification Opportunities for Caribou Biosciences and Conduit Pharmaceuticals

-0.18

Correlation Coefficient

Caribou Biosciences  Conduit Pharmaceuticals

Good diversification

The 3 months correlation between Caribou and Conduit is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and Conduit Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Conduit Pharmaceuticals and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with Conduit Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Conduit Pharmaceuticals has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and Conduit Pharmaceuticals go up and down completely randomly.

Pair Corralation between Caribou Biosciences and Conduit Pharmaceuticals

Given the investment horizon of 90 days Caribou Biosciences is expected to under-perform the Conduit Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Caribou Biosciences is 5.29 times less risky than Conduit Pharmaceuticals. The stock trades about -0.03 of its potential returns per unit of risk. The Conduit Pharmaceuticals is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  1.10  in Conduit Pharmaceuticals on September 29, 2024 and sell it today you would lose (0.51) from holding Conduit Pharmaceuticals or give up 46.36% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	60.32%
Values	Daily Returns

Caribou Biosciences  vs.  Conduit Pharmaceuticals

Caribou Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Caribou Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental drivers remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Conduit Pharmaceuticals

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Conduit Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Conduit Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Caribou Biosciences and Conduit Pharmaceuticals

The main advantage of trading using opposite Caribou Biosciences and Conduit Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, Conduit Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Conduit Pharmaceuticals will offset losses from the drop in Conduit Pharmaceuticals' long position.

The idea behind Caribou Biosciences and Conduit Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.